Kamke Trent G 4

What Happened Trent G. Kamke, Senior Vice President, Operations at LEMAITRE VASCULAR, was credited with a total of 11.889 dividend-equivalent rights on June 4, 2026. The Form 4 reports seven derivative awards (transaction code A) — 0.82, 0.82, 1.403, 1.682, 1.881, 2.131 and 3.152 shares — all acquired at $0.00 (no cash changed hands). These are dividend-equivalent rights tied to earlier restricted stock unit (RSU) and performance share unit (PSU) awards and are the economic equivalent of common shares.

Key Details

• Transaction date: 2026-06-04; Form 4 filed 2026-06-05 (timely).
• Each entry shows acquisition at $0.00 (derivative awards, code A); total credited = 11.889 shares; reported value = $0.
• Reported tranches and related award grant dates (per footnotes):
  • 0.82 (F1) — dividend equivalent from RSU granted 12/12/2022
  • 0.82 (F2) — dividend equivalent from PSU granted 12/12/2022
  • 1.403 (F3) — dividend equivalent from RSU granted 12/8/2023
  • 1.682 (F4) — dividend equivalent from PSU granted 12/8/2023
  • 1.881 (F5) — dividend equivalent from RSU granted 12/6/2024
  • 2.131 (F6) — dividend equivalent from PSU granted 12/6/2024
  • 3.152 (F7) — dividend equivalent from RSU granted 12/10/2025
• Shares owned after the transaction: not specified in the provided excerpt of the filing.
• No 10b5-1, sale, tax-withholding, or exercise indications in these entries; these are accruals/credits tied to existing awards.

Context Dividend-equivalent rights are common: they accrue on time- or performance-based equity awards and are typically paid or settled in shares (or cash) as those awards vest. These entries do not represent an open-market buy or sale and do not by themselves indicate a change in insider sentiment; they are administrative credits tied to previously granted RSUs/PSUs.